7 must-reads for supply chain leaders this week

Here are seven articles published by Becker's Hospital Review this past week highlighting critical issues on the minds of supply chain leaders and how medical devices are named, among other topics.

1. How medical devices are named: 5 thoughts from a branding expert
Developing a new name for a medical device is difficult. The process requires much time, patience, resiliency and an open mind, according to Mike Pile, president and creative director of Uppercase Branding.

2. 6 things keeping supply chain leaders up at night
East Lansing-based Michigan State University partnered with the APICS Supply Chain Council to identify critical issues on the minds of supply chain leaders.

3. Which news channel covers high drug costs the most?
While high prescription drug costs affect millions of Americans, and lawmakers are constantly working to tackle the issue, televised evening news programs rarely report on rising medication costs, according to a study from the progressive nonprofit research group Media Matters.

4. 7 things to know about Dr. Scott Gottlieb's relationship with the drug industry
Scott Gottlieb, MD, President Donald Trump's nominee to head the Food and Drug Administration, has previously worked as a deputy commissioner at the FDA, practiced medicine as a physician and served as a consultant and investor in the pharmaceutical industry — a role some worry will create a conflict of interest if he's confirmed to lead the regulatory agency

5. Patients often skip, delay or ration cancer treatments due to high drug costs: 5 takeaways
Hundreds of thousands of Americans with cancer delay filling prescriptions, cut pills in half or skip drug treatment altogether due to the exorbitant cost of new cancer drugs, reports Kaiser Health News.

6. Sen. Sanders to Trump: Don't give Sanofi monopoly on Zika vaccine
Sen. Bernie Sanders, I-Vt., is urging President Donald Trump to block the U.S. Army from giving Paris-based Sanofi exclusive rights to patents for a Zika vaccine.

7. 6 global drug pricing policies and how they would affect US drug spending
The Pew Charitable Trusts recently assessed the policies other high-income countries use to manage prescription drug spending.

More articles on supply chain:

Patients often skip, delay or ration cancer treatments due to high drug costs: 5 takeaways
7 things to know about Dr. Scott Gottlieb's relationship with the drug industry
Mylan settles biosimilar patent dispute with Roche: 4 things to know

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.